Genetics Investing

BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Biotech Investing

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+ in Prostate Cancer

Biotech Investing

Arcellx

Genetics Investing

BriaCell Announces Proposed Effective Date of Share Consolidation

Biotech Investing

Fulgent Genetics

Genetics Investing

Veracyte

Genetics Investing

PTC

Genetics Investing

iShares Genomics Immunology and Healthcare ETF

Genetics Investing

Guardant Health

Genetics Investing

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+ for Cancer

Biotech Investing

Fulgent Reports Second Quarter 2025 Financial Results

Genetics Investing

23andMe Collapses: DNA Testing Giant Files for Bankruptcy, CEO Resigns

Genetics Investing

Latest genetics News

More genetics News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES